About this trial
To evaluate the clinical significance of optical coherence tomography (OCT) in interventional treatment of intracranial atherosclerotic stenosis (ICAS).
Eligibility criteria
Qualifiers
Symptomatic ICAS. Participants with ICAS with a transient ischaemic attack (TIA) or stroke attributable to the territory of the stenotic artery were defined as symptomatic. A TIA was defined as a transient episode of neurological dysfunction (focal weakness or language disturbance, transient monocular blindness, or required assistance in walking) caused by focal brain or retinal ischaemia that lasted for at least 10 minutes but resolved within 24 hours
Stenotic degree ≥ 50%, measured by digital subtraction angiography
The stenosis must located in at least one major intracranial artery (internal carotid artery, vertebral artery, middle cerebral artery, or basilar artery)
Disqualifiers
Arteriovenous Malformation
Aneurysm
Trial design
Treatments tested in this trial
- Optical Coherence Tomography
- Percutaneous transluminal angioplasty and stenting
Treatment groups
Sponsors and collaborators
jiaoliqun
Lead sponsor
Xuanwu Hospital, Beijing
Sponsor institution